Psoriasis, a chronic relapsing disorder affecting 2-3% of the population (5, 10) , may vary in severity from a few small areas of scaling to a generalised illness. Therapeutic measures for the mild form of the disease include topical tar preparations steroids and dithranol (6) . For patients with extensive disease, oral methotrexate, hydroxyurea, or a combination of oral psoralens and exposure to long wave ultraviolet light (PUVA) have been recommended (6) . Although PUVA (which was first tried in 1973) has proved to be quite effective, it has been observed to be associated with an increased risk of squamous cell cancer of skin and therefore remains an experimetntal form of therapy (10, 23) , The incidental observation that psoriatic lesions cleared when a patient with chronic renal failure was subjected to hemodialysis (17) has led to attempts to treat non-uremic psoriatics with dialysis (8, 23) ,
Remissions of long-standing plaque psoriasis have been reported with both hemodialysis and peritoneal dialysis (1, 7, 8, 17, 18, 22, 24, 25) . The lesions may begin to regress as early as two days after the first dialysis (7, 25) and complete clearing has required 1-9 dialyses (1, 7, 8, 17, 18, 22, 24, 25) , Dramatic relief of symptoms of psoriatic arthritis has also been recorded (1, 22) . The major problem encountered during hemodialysis of nonuremic psoriatics has been the difficulty in maintaining patency of shunts and fistulae (3, 7) ; but this problem has been overcome by using percutaneous femoral vein catheterisation for access to the circulation (7), With peritoneal dialysis there is an increased risk of peritonitis when the abdominal skin is involved (25) . Patients with pustular psoriasis have uniformly failed to improve with dialysis (1, 15, 25) ,
The recurrence of lesions in some patients while still on dialysis (14, 21) and the reported occurrence of psoriasis de novo during chronic dialysis have cast considerable doubt on the value of dialysis in psoriasis (2, 11) . Moreover, psychological factors have been postulated to help achieve a therapeutic response in psoriasis (12) , Of considerable interest are two studies in which sham-dialysed controls were included (7, 19) , In one study no benefit from four 6-hour hemodialyses on consecutive days was observed in 7 patients (19) ; but in a several study, There was complete clearance following hemodialysis in two patients who had not responded to sham dialysis (7) . Thus, the controversy regarding the placebo effect of dialysis on psoriatic lesions remains unresolved.
Blood purification techniques other than dialysis have also been tried in a few patients. Of six patients treated with hemoperfusion, four had a complete remission and two patients showed improvement. However, of seven patients put on haemofiltration, only one had a complete remission (16) ,
The mechanism by which dialysis induces a remission is not clear. It has been suggested that dialysis may remove a psoriatic factor that cannot be excreted by normal kidneys (17) . Psoriatic scales contain substances which are chemotactic for neutrophils (9, 26) and it is possible that products elaborated by leukocytes may result in enhanced epidermal proliferation which is the hallmark of psoriasis (6), Hemodialysis could inhibit this process because of its known inhibitory effect on neutrophil chemotactic responsiveness (13) . Because of the molecular size of heparin, only minute quantities are absorbed during peritoneal dialysis, making it unlikely that heparin plays a role (20) , Other hypoth include removal of growth promoting factors capable of stimulating epidermal mitosis, removal of an inhibitor to epidermal chalone, stress induced hormone production, and the production of an unphysiologic state because of large variations in osmolality, pH, essential amino-acids, or trace element concentrations (5, 18) , The marked variation in the duration of remission after stopping dialysis (8, 14, 18, 20, 25) is also unexplained. The recent observation that psoriasis may regress after cardiac surgery requiring cardiopulmonary bypass oxygenation suggests there may be some factor in common between dialysis and cardiopulmonary bypass (4),
In conclusion, there is still no unequivocal evidence that dialysis induced remission in patients units psoriasis, Further controlled studies using large number of patients are needed. If the beneficial effects of dialysis are confirmed, useful clues may emerge that might help unveil the complexities of the pathogenesis of this unusually complex disease.
